Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Calgary
$27,000.00
Characterizing interactions between heat-inactivated human serum and Pseudomonas aeruginosa gene expression
FY 2025-26
Summary
Microbes are tiny organisms that are too small to see with the naked eye. When microbes evolve defense mechanisms that make medications ineffective, this is called antimicrobial resistance. In 2019, bacterial antimicrobial resistance is estimated to have directly caused 1.27 million deaths worldwide. One commonly used antimicrobial is silver. Physicians use silver-containing dressings to prevent infection in wounds. For example, Canada’s standard of care for burn wounds includes silver-containing dressings. However, unpublished data from our lab suggests that the effectiveness of silver in clinical trials is surprisingly low. Our data also suggests that the bacteria Pseudomonas aeruginosa (P. aeruginosa) is frequently found in wounds even after they have been treated with silver. P. aeruginosa is a serious global health concern. In 2021, P. aeruginosa contributed to approximately 8.6% of global deaths linked to antimicrobial resistance. Despite silver’s widespread use, we still don’t fully understand how P. aeruginosa resists it. By uncovering the bacterium’s resistance mechanism, we may be able to find ways to disrupt it and make silver treatments more effective. Our lab has discovered a component in human serum (part of blood) that may aid P. aeruginosa resist silver’s antimicrobial effects. My research seeks to uncover this mystery by analyzing how P. aeruginosa changes itself to interact with human serum using biochemical analysis.
Department
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
573180
Name
Cui Caroline
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterizing interactions between heat-inactivated human serum and Pseudomonas aeruginosa gene expression
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Bacterial Physiology; Chronic Wounds; Gene Expression; Human Serum; Pseudomonas Aeruginosa; Rna Sequencing; Silver Resistance
Abstract
Microbes are tiny organisms that are too small to see with the naked eye. When microbes evolve defense mechanisms that make medications ineffective, this is called antimicrobial resistance. In 2019, bacterial antimicrobial resistance is estimated to have directly caused 1.27 million deaths worldwide. One commonly used antimicrobial is silver. Physicians use silver-containing dressings to prevent infection in wounds. For example, Canada’s standard of care for burn wounds includes silver-containing dressings. However, unpublished data from our lab suggests that the effectiveness of silver in clinical trials is surprisingly low. Our data also suggests that the bacteria Pseudomonas aeruginosa (P. aeruginosa) is frequently found in wounds even after they have been treated with silver. P. aeruginosa is a serious global health concern. In 2021, P. aeruginosa contributed to approximately 8.6% of global deaths linked to antimicrobial resistance. Despite silver’s widespread use, we still don’t fully understand how P. aeruginosa resists it. By uncovering the bacterium’s resistance mechanism, we may be able to find ways to disrupt it and make silver treatments more effective. Our lab has discovered a component in human serum (part of blood) that may aid P. aeruginosa resist silver’s antimicrobial effects. My research seeks to uncover this mystery by analyzing how P. aeruginosa changes itself to interact with human serum using biochemical analysis.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Cui, Caroline
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~